Gregori Casals
Featured publications
-
Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma
Authors:Reference: Hepatology 2020. -
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide.
Authors:Reference: Frontiers In Immunology 2017. -
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display antiinflammatory properties in rats with liver fibrosis
Authors:Reference: Journal Of Hepatology 2016. -
Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes
Authors:Reference: American Journal Of Physiology-Heart And Circulatory Physiology 2009.
Featured Projects
-
THERANANO: Determining the therapeutic use in liver diseases of advanced antioxidant conjugates based on cerium oxide nanoparticles
Principal investigator: Gregori Casals MercadalFunder: Instituto de Salud Carlos III (Spain) (Programa financiador competitivo)Code: PI19/0074Duration: 01/01/2020 - 31/12/2022 -
Evaluation of antioxidant and anti-inflammatory properties of cerium oxide nanoparticles as novel therapeutic strategy in hepatic steatosis.
Principal investigator: Gregori Casals MercadalFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación SanitariaDuration: 01/01/2016 - 01/01/2018 -
Cerium oxide nanoparticles as a new therapeutic tool for tissue regeneration in liver diseases
Principal investigator: Víctor Franco PuntesDuration: 01/01/2013 - 01/01/2015 -
Basic and translational implications of the functional and molecular alterations of the hepatic endothelium in cirrhosis
Principal investigator: Manuel Morales RuizDuration: 01/01/2011 - 01/01/2013 -
Pathophysiological role of activated liver endothelial cells in cirrhosis. Possible therapeutical implications
Principal investigator: Manuel Morales RuizDuration: 01/01/2008 - 01/01/2010